GKB Ophthalmics Limited (BOM:533212)
India · Delayed Price · Currency is INR 63.56
+1.66 (2.68%)
At close: Aug 21, 2026
GKB Ophthalmics Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 320 | 265 | 304 | 440 | 547 | 464 | |
Market Cap Growth | -20.46% | -12.99% | -30.82% | -19.65% | 17.99% | 12.20% |
Enterprise Value | 413 | 324 | 304 | 440 | 564 | 457 |
Last Close Price | 63.56 | 52.50 | 60.34 | 87.22 | 108.55 | 92.00 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 9.88 | 21.72 | - | - | - | 36.39 |
PS Ratio | 0.21 | 0.18 | 0.28 | 0.50 | 0.73 | 0.65 |
PB Ratio | 0.58 | 0.48 | 0.54 | 0.69 | 0.81 | 0.69 |
P/TBV Ratio | 0.61 | 0.50 | 0.58 | 0.74 | 0.87 | 0.74 |
P/FCF Ratio | - | - | - | 20.50 | - | 149.35 |
P/OCF Ratio | - | - | - | 10.42 | - | 9.15 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.28 | 0.22 | 0.28 | 0.50 | 0.75 | 0.64 |
EV/EBITDA Ratio | 3.98 | 3.78 | - | 76.15 | 15.32 | 9.22 |
EV/EBIT Ratio | 5.78 | 6.04 | - | - | 65.90 | 19.99 |
EV/FCF Ratio | - | - | - | 20.52 | - | 147.10 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.21 | 0.21 | 0.26 | 0.18 | 0.17 | 0.17 |
Debt / EBITDA Ratio | 1.06 | 1.36 | - | 19.88 | 3.04 | 2.37 |
Debt / FCF Ratio | - | - | - | 5.36 | - | 37.86 |
Net Debt / Equity Ratio | 0.13 | 0.13 | 0.03 | -0.09 | -0.04 | -0.06 |
Net Debt / EBITDA Ratio | 0.66 | 0.84 | -0.53 | -9.90 | -0.79 | -0.82 |
Net Debt / FCF Ratio | - | -1.50 | -0.28 | -2.67 | 0.73 | -13.07 |
Asset Turnover | - | 1.16 | 0.91 | 0.78 | 0.68 | 0.65 |
Inventory Turnover | - | 2.04 | 1.64 | 1.53 | 1.26 | 1.24 |
Quick Ratio | - | 0.71 | 0.62 | 0.99 | 1.05 | 0.93 |
Current Ratio | - | 1.52 | 1.59 | 1.89 | 2.03 | 1.95 |
Return on Equity (ROE) | - | 5.44% | -11.74% | -4.54% | 0.17% | 2.91% |
Return on Assets (ROA) | - | 2.61% | -3.15% | -1.28% | 0.48% | 1.32% |
Return on Invested Capital (ROIC) | 12.10% | 8.72% | -10.37% | -3.77% | 1.12% | 3.66% |
Return on Capital Employed (ROCE) | - | 8.80% | -9.60% | -3.40% | 1.20% | 3.20% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 10.12% | 4.61% | -23.16% | -6.39% | -0.31% | 2.75% |
FCF Yield | -15.09% | -18.27% | -18.34% | 4.88% | -7.29% | 0.67% |
Buyback Yield / Dilution | -0.14% | - | - | - | - | -0.01% |